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1. "Conformational Features of Distamycin-DNA and Netropsin-DNA Complexes by Raman 
Spectroscopy" by J.C. Martin, R.M. Wartell and D.C. O'Shea Proc.Nat.Acad.Sci. 
In press. 
Progress Report  
The overall aims of the research project are to gain an understanding of how DNA 
binding ligands discriminate between different base pair sequences, and how one region 
of DNA influences the conformation of adjacent regions. There are two specific objectives 
of the project. One objective is to determine detailed information about the complexes 
which netropsin (Nt) and distamycin (Dt) form with A•T sequences of duplex DNA. These 
two oligopeptide molecules are of interest as antibiotics and as simplified models of 
proteins which bind to specific DNA sites. They have been shown to specifically bind to 
A-T regions of duplex DNAs. They do not bind single stranded DNA, RNA ) or GC DNA polymers 
under conditions (0.111 sodium ion) in which they hind to AT DNA polymers. The second 
objective is to examine the conformational properties of block DNA oligomers d(C15A15)• 
d(T15G15) and d(C15A5)•d(T 5G15). These oligomers have a block of A•T pairs joined to a 
block of G•C base pairs. These two sequences, cil(A) x •d(T) x and d(G) y •d(C) y (where x and 
y are the number of base pairs), show different conformational properties at polymer 
lengths. pray diffraction studies on fibers of poly d(A)•poly d(T) show it to be in the 
"B" type conformation. Similar studies show that pOly d(G)• poly d(C) under similar 
conditions is in the "A" type conformation. We wish to examine the conformation of this 
DNA by Raman Spectroscopy. This technique is also being employed in the drug-DNA binding 
experiments. 
There are four goals this year for the drug-DNA binding studies. The first is to 
obtain the Raman spectra of Nt and Dt in the free state and bound to calf thymus DNA. 
The second objective is to obtain the Raman spectra of molecules which are molecular 
subnits of Dt and Nt (described below). The third goal is to formulate and apply a 
normal mode calculation to the molecular subunits as well as the drugs. By combining 
the results of the second and third goals it should be possible to assign the frequencies 
of the drugs' Raman bands to vibrational motions of specific regions of the drugs. Many 
of these goals have been achieved.(see below). 
The major goal for the study on the block oligomer DNAs is to synthesize!-I-2 mgs of 
d(C15A5)•d(T5G15) and carry out characterization and preliminary Raman spectroscopy studies. 
Several steps in the synthesis have been accomplished so far. 
RESULTS: The enclosed manuscript describes the results to date on Nt and Dt binding 
to DNA. Raman spectra have been obtained of the drugs in the presence and absence of calf 
thymus DNA. Methods were devised to determine a bound drug's Raman spectra in the presence 
of DNA and solvent. A computer subtraction technique was developed to remove DNA and 
solvent background from the total spectra. Several changes occur in the Raman spectra of 
these drugs upon binding DNA. To analyze these changes, it was necessary to assign 
specific motions to the observed Raman bands. The first approach to this problem was to 
examine the Raman spectra of pyrrole, N-methyl pyrrole and N-methyl pyrrole carboxaldehyde, 
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Progress Report 
and correlate these spectra to the drug spectra. Some empirical correlations of bands 
were possible, however a more fundamental understanding of the vibrational characteris-
tics of the molecules was necessary. A normal mode calculation was formulated for 
asymmetric molecules and applied to pyrrole, its derivatives and the central portion 
of both drugs. A very good correlation was obtained between many observed band frequencies 
of Nt and Dt and the predicted frequencies. This allowed confident assignments for 
these bands. The analysis of the differences between bound and unbound distamycin 
spectra indicated that pyrrole ring and peptide group vibrations are altered when Dt 
binds to DNA. The environment of the pyrrole ring methyl groups are not affected by the 
binding. The results suggest that the pyrrole ring N1 position (where the methyl groups 
are) are logical sites for chemical modifications aimed at creating cell uptake selectively 
while waintaining DNA binding activity. - Analysis of the spectra of Nt gave similar 
results. However, due to the lower solubility limit of Nt in aqueous solution ( and thus 
reduced Raman intensities), it was not possible to quantify changes in the peptide group 
vibration. 
The synthesis pf the block DNA polymers has made some progress, however, it is 
uncertain if the orginal goal for this year will be met. Part of the delay has been 
necessitated by the building of a gel scanner, and the isolation of N.luteus DNA 
polymerase. 25 trig. of poly(dI)•poly(dC) was synthesized, and about 6-8 mg of poly(dC) 
is now digested to (dC) x oligomers. The techniquecof analytical gel electrophoresis 
and RPC-5 (Reverse Phase Chromatography) have been developed. 
Research goals for the coming year are to complete the synthesis of d(C15A5). 
d(T5G15) if it is not yet completed and construct d(C15A15)•d(T15G15). Raman studies 
on these block oligomers in aqueous solution will be carried out. Further studies 
on the binding of Nt and Dt to DNA will focus on one or two bands of their Raman 
spectra involved in peptide vibrations. By quantitatively examining these bands at 
different molar ratios of drug to DNA it may be possible to determine the number of 
hydrogen bonds involved in the drug-DNA complexes. Theoretical low energy calculations 
of the drug complexed to DNA will also be made. 
The undersigned agrees to accept responsibility for the scientific 
and technical conduct of the project and for provision of required 
progress reports If a grant is awarded as the result of this application. 
.7,  
Date 
, 	7/ la,IEV 
Principal Investigator or Program 
Director 
